Covid Vaccine Germany Canada Coronavirus Covid Vaccine Germany Canada

Drugmakers partner to develop COVID-19 vaccines aimed at new variants

Reading now: 243
globalnews.ca

vaccines targeting emerging variants of COVID-19 amid concerns that some mutations are making the virus harder to combat. Tam warns of coronavirus variants as new cases emerge across Canada GSK plans to invest 150 million euros ($181 million) to support the research of the Tubingen, Germany-based CureVac, which is developing vaccines that use messenger RNA to attack the disease.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA